EFFICACY AND SAFETY OF SYSTEMIC CHEMOTHERAPY IN PATIENTS WITH ADVANCED MYCOSIS FUNGOIDES AND SEZARY SYNDROME: A RETROSPECTIVE STUDY OF 94 CASES

被引：0
|
作者：
Henao Viviana, Paredes [1 ]
Eva, Gonzalez-Barca [1 ]
Eva, Domingo [1 ]
Santiago, Mercadal [1 ]
Esmeralda, De La Banda [1 ]
Fina, Climent [1 ]
Cristina, Muniesa [1 ]
Anna, Sureda [1 ]
De Sevilla Alberto, Fernandez [1 ]
Teresa, Estrach [2 ]
Guillermo Armando, Lopez [2 ]
Octavio, Servitje [1 ]
机构：
[1] Hosp Univ Bellvitge, Ico, Lhospitalet De Llobregat, Spain
[2] Hosp Clin Barcelona, Barcelona, Spain
来源：
HAEMATOLOGICA | 2016年 / 101卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
PC-253
引用
收藏
页码：230 / 231
页数：2
相关论文
共 50 条
  • [41] Prognostic Factors, Staging and Treatments in Advanced Stage Mycosis Fungoides and Sezary Syndrome
    Talpur, Rakhshandra
    Alberti-Violetti, Silvia
    Schilti, Megan
    Sui, Dawen
    Duvic, Madeleine
    BLOOD, 2014, 124 (21)
  • [42] Validity assessment of the CTCL-SI in advanced mycosis fungoides/Sezary syndrome
    Goldfeder, K. L.
    Troxel, A. B.
    Introcaso, C. E.
    Rook, A. H.
    Kim, E. J.
    JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2007, 127 : S56 - S56
  • [43] Preliminary Data from the retrospective Multicenter Study on the Use and Response of Chloromethine Gel in Patients with Mycosis fungoides/Sezary Syndrome with or without combined Systemic Therapy
    Hoffmann, J. C.
    Booken, N.
    Hansen, I.
    Dobos, G.
    Kleiner, P. L.
    Wobser, M.
    Glatzel, C.
    Huening, S.
    Flaig, M.
    Michalowitz, A. L.
    Klemke, C. D.
    Schoen, M. P.
    Mitteldorf, C.
    JOURNAL DER DEUTSCHEN DERMATOLOGISCHEN GESELLSCHAFT, 2024, 22 : 13 - 14
  • [44] Diagnostics and treatment of mycosis fungoides and Sezary syndrome in West Sweden: a retrospective register-based study of 82 patients
    Wojewoda, Karolina
    Osmancevic, Amra
    EUROPEAN JOURNAL OF CANCER, 2021, 156 : S67 - S67
  • [45] Assessing the efficacy of mogamulizumab: a novel tool for the management of mycosis fungoides and Sezary syndrome
    Wilding, Samuel
    Molloy, Kevin
    Scarisbrick, Julia
    Farquharson, Nina
    Parry, Eileen
    Cowan, Richard
    EUROPEAN JOURNAL OF CANCER, 2021, 156 : S17 - S18
  • [46] Quality of life in patients with mycosis fungoides and Sezary syndrome: a review of the literature
    Ottevanger, Rosanne
    van Beugen, Sylvia
    Evers, Andrea
    Willemze, Rein
    Vermeer, Maarten
    Quint, Koen
    EUROPEAN JOURNAL OF CANCER, 2021, 156 : S65 - S65
  • [47] The incidences of other primary cancers in patients with mycosis fungoides and Sezary syndrome
    Blazewicz, Izabela
    Olszewska, Berenika
    Stawczyk-Macieja, Marta
    Jaskiewicz, Maciej
    Nowicki, Roman J.
    Sokolowska-Wojdylo, Malgorzata
    POSTEPY DERMATOLOGII I ALERGOLOGII, 2021, 38 (02): : 289 - 294
  • [48] Phase II study of alemtuzumab (Campath-1H) in patients with advanced mycosis fungoides/Sezary syndrome.
    Hagberg, H
    Lundin, J
    Repp, R
    Eriksson, M
    Juliusson, G
    Norberg, B
    Wiklund, T
    Cavalin-Stahl, E
    Osterborg, A
    BLOOD, 2001, 98 (11) : 806A - 806A
  • [49] Maintenance therapy in patients with mycosis fungoides or Sezary syndrome: A neglected topic
    Stadler, Rudolf
    Scarisbrick, Julia J.
    EUROPEAN JOURNAL OF CANCER, 2021, 142 : 38 - 47
  • [50] Mogamulizumab-Associated Rash in Patients With Mycosis Fungoides and Sezary Syndrome
    Foley, Nicole
    Minor, Chelsea
    Musiek, Amy
    Mehta-Shah, Neha
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2023, 23 : S464 - S464
12345